Detalhe da pesquisa
1.
Prevalence and risk factors for secondary hypertension among young Korean men.
Rev Cardiovasc Med
; 21(4): 627-634, 2020 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33388008
2.
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial.
JAMA
; 323(23): 2407-2416, 2020 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32543684
3.
Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stentã- 3-Year Outcomes From the HOST-ASSURE Randomized Clinical Trial.
Circ J
; 83(7): 1489-1497, 2019 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31155604
4.
Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial.
JAMA
; 314(20): 2155-63, 2015 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26556051
5.
Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study.
Circulation
; 125(3): 505-13, 2012 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22179532
6.
Ticagrelor Monotherapy After 3-Month Dual Antiplatelet Therapy in Acute Coronary Syndrome by High Bleeding Risk: The Subanalysis From the TICO Trial.
Korean Circ J
; 52(4): 324-337, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35129317
7.
Effect of Intravascular Ultrasound-Guided Drug-Eluting Stent Implantation: 5-Year Follow-Up of the IVUS-XPL Randomized Trial.
JACC Cardiovasc Interv
; 13(1): 62-71, 2020 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31918944
8.
A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trial.
J Am Coll Cardiol
; 63(25 Pt A): 2805-16, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24814486
9.
Usefulness of intravascular ultrasound to predict outcomes in short-length lesions treated with drug-eluting stents.
Am J Cardiol
; 112(5): 642-6, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23711810
10.
Left atrial function assessed by Doppler echocardiography rather than left atrial volume predicts recurrence in patients with paroxysmal atrial fibrillation.
Clin Cardiol
; 36(4): 235-40, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23495006
11.
Preventive effect of pretreatment with intravenous nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (PRINCIPLE Study).
Yonsei Med J
; 54(4): 957-64, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23709432
12.
Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
JACC Cardiovasc Interv
; 6(9): 932-42, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24050860
13.
Spontaneous sinus conversion of permanent atrial fibrillation during treatment of hyperkalemia.
Korean Circ J
; 42(1): 65-8, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22363388
14.
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation).
J Am Coll Cardiol
; 60(15): 1340-8, 2012 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22999717
15.
The 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial: study protocol for a randomized controlled trial.
Trials
; 13: 29, 2012 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-22463698
16.
Five-year outcomes of sirolimus-eluting versus paclitaxel-eluting stents: a propensity matched study: clinical evidence of late catch-up?
Int J Cardiol
; 152(3): 302-6, 2011 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20708806
17.
Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial.
J Am Coll Cardiol
; 58(18): 1844-54, 2011 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22018294